Quantcast
 
New ETF Book by Larry Connors - Click here to read more


 

Ingenix Survey Finds Physicians Have Limited Understanding of new Government Stimulus Incentives for EHRs

Wed. November 04, 2009; Posted: 11:01 AM
Stocks RSS

Look up the PowerRating of UNH and see how it has performed over the past week as well as the current proprietary PowerRating.

EDEN PRAIRIE, Minn., Nov 04, 2009 (BUSINESS WIRE) -- UNH | Quote | Chart | News | PowerRating -- --Ingenix Launches EHR/Stimulus Education Program to Help Physicians Maximize ARRA Incentives, Value of EHR Technologies in Their Practices

A recent survey found that cost is the top concern among physicians considering electronic health records (EHRs) for their practices. Also, survey respondents had limited understanding of the financial assistance for implementing an EHR system now available to physicians through the American Recovery and Reinvestment Act (ARRA).

In response to these findings, Ingenix has launched a nationwide EHR/stimulus education initiative to help physicians learn how EHR technologies and financial incentives can support their efforts to enhance patient care.

Ingenix conducted the online survey of 1,001 U.S. physicians and physician practice administrators to gauge attitudes toward EHR technologies, and to understand how federal stimulus incentives might affect purchase decisions. Key findings include:

More than half (58 percent) of respondents have little or no familiarity with the ARRA, while 42 percent have some familiarity with its provisions. Still, 82 percent say they are more likely to purchase EHR technologies if they are reimbursed for their investment, including 34 percent who would be much more likely to do so. Additionally, 77 percent say that penalties for not adopting EHR technology by 2014, as prescribed by the provisions of the ARRA stimulus, are likely to motivate them to implement the technology.

The Ingenix EHR/stimulus education program features a webinar series that will help physicians better understand the ARRA incentives for EHR adoption and their eligibility requirements. Ingenix also launched a new online EHR/stimulus education resource center (www.ingenix.com/ehr) that features additional details about ARRA provisions and tools to help physicians assess their needs, advice for selecting and reviewing EHR systems, and cost and savings information. Webinar registration and scheduling details also are available on the site.

"Ingenix is meeting a critical need by providing physicians with the practical information they need to make decisions about EHRs," said Kim LaFontana, vice president, Ingenix. "While our survey indicates that the federal stimulus incentives hit one of the sweet-spots in addressing physicians' primary concern -- reimbursing them for the cost of the technology -- it also shows that there is a real need for HIT companies to provide solutions and assistance in making the technology a productive addition to the physician practice, not a drag on productivity. Ingenix is helping physicians get the most of this opportunity and select an EHR system that supports their biggest priority -- caring for patients."

EHRs reduce or eliminate the need for paper charts, and improve access to patient-specific health information and medical knowledge at the point of care. As such, health care policymakers believe EHRs are integral to improving the quality and affordability of health care services. The federal stimulus incentives promote widespread EHR adoption by providing $19 billion in special Medicare reimbursement payments -- up to $44,000 per physician over a five-year period -- to practices that demonstrate meaningful use of the technology.

Ingenix CareTracker EMR is a Web-based electronic health record solution that fully integrates with all the operational functions of a physician practice. Ingenix CareTracker offers three modules to support physician practice operations: Ingenix CareTracker PM optimizes administrative workflows for physician practices; Ingenix CareTracker EMR helps clinicians enter, retrieve and correlate patient information at the point of care; and Ingenix CareTracker Services improves revenue cycle management with comprehensive billing and accounts receivable support. For more information, visit www.ingenix.com/caretracker.

The Ingenix survey has a margin of error of 3.1 percent.

About Ingenix

Ingenix, a UnitedHealth Group (NYSE: UNH | Quote | Chart | News | PowerRating) company, is a leading provider of health information, technologies and consulting services. Organizations, institutions, businesses and government agencies that comprise the health care system depend on Ingenix solutions and insights to improve their performance. Visit www.ingenix.com for more information.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6091689&lang=en

SOURCE: Ingenix

Ingenix 
Kyle Christensen, 952-833-7446 
kyle.christensen@ingenix.com
For full details on UnitedHealth Group Inc. (UNH) click here. UnitedHealth Group Inc. (UNH) has Short Term PowerRatings of 4. Details on UnitedHealth Group Inc. (UNH) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [UNH]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.